Last but not least, He et al. treated PCOS and non-PCOS patients with different doses of testosterone and described significantly elevated PPARγ mRNA and protein levels in the experimental group, with PPARγ positively correlating with testosterone concentration [56]. This evidence concerns the gene PPARG and polycystic ovary syndrome.